DCM
MTEM

Diag Capital Management’s Molecular Templates, Inc. MTEM Stock Holding History

Diag Capital Management’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$985K Buy
+16,256
New +$1.13M 1.13% 28

Other funds holding MTEM

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Diag Capital Management's MTEM Position: Q4 2018 in Review

Diag Capital Management opened a new position in Molecular Templates, Inc. (MTEM) in Q4 2018: 16,256 shares worth $985K. The stake represents 1.13% of the portfolio and ranks #28 among its holdings.

62 funds tracked by Wall St. Rank hold MTEM as of Q4 2018.

  • Diag Capital Management held 16,256 shares of Molecular Templates, Inc. worth $985K as of Q4 2018.
  • Molecular Templates, Inc. was a new Diag Capital Management position in Q4 2018.
  • Molecular Templates, Inc. made up 1.13% of Diag Capital Management's portfolio in Q4 2018, its #28 holding.
  • 62 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q4 2018.

Based on Diag Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.